UBS Maintains Neutral on Scotts Miracle Gro, Raises Price Target to $78

Benzinga Newsdesk www.benzinga.com Positive 66.4%

Neg 0% Neu 0% Pos 66.4%

UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and raises the price target from $70 to $78.